Robert Berman

Robert Berman is the current CEO of Hancock Jaffe Laboratories. Prior to this, they served as the CEO of Northwestern University Pritzker School of Law from June 2007 to September 2009. Robert also worked as a consultant from August 2017 to March 2018, where they served as a strategic advisor for technology, medtech, and healthcare companies. From September 2012 to July 2017, they were the President and CEO of ITUS Corporation, where they were responsible for turnaround, uplist to Nasdaq, recapitalization, re-branding, corporate governance, and co-founder of Anixa Diagnostics - Liquid Biopsy subsidiary. Robert has also served as a board member for IP Dispute Resolution Corporation from January 2007 to September 2012.

Robert Berman completed a B.S. in Entrepreneurial Mgmt. from The Wharton School and a JD from Northwestern University Pritzker School of Law.

Brian Roselauf - Director of Research and Development, Marc Glickman - Senior Vice President and Chief Medical Officer, and Craig Glynn - Interim Chief Financial Officer report to Robert Berman.